About this document

Azithromycin Use and Cancer Risks by Henok is a document available to read on EtoBox.

The FDA has issued a warning against the long-term use of Azithromycin due to its association with an increased risk of cancer relapse. Azithromycin is approved for short-term treatment of certain bacterial infections, and patients are advised to consult their doctors before using it for extended periods. Manufacturers are required to provide a medication guide outlining the risks each time the drug is dispensed.

Author

Henok

Language

EN